It is therefore in this context, where treatment options for obesity remain very limited, that the appearance of Ozempic and Mounjaro on the market is currently generating enormous interest, both in the medical and scientific communities and in the general population
Evidence shows that surgery provides added, durable benefits beyond medications alone. Prior research showed bariatric surgeries decreased from 2022 to 2023, while GLP-1 use grew by 132.6% during that time, though surgery may present certain benefits, such as cost-effectiveness, over the anti-obesity medications
Could the combination produce unexpected effects that neither medication causes alone
What side effects should I watch for if I have hyperthyroidism
On the other hand, another meta-analysis showed that GLP-1 RAs reduced the risk of CV death [Risk Ratio (RR), 0.90